In these analyses, individuals who were positive for the SE and persistently positive at baseline and 1 year for anti-CCP3 >60 units, and dual RF-IgA and RF-IgM had the highest rate of incident clinical IA/RA (Figure 2A). This evidence concerns the gene CD40LG and rheumatoid arthritis.